Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $3.97 Million - $4.97 Million
21,000 New
21,000 $4.07 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $24.2 Million - $27.6 Million
-94,400 Reduced 94.97%
5,000 $1.39 Million
Q4 2022

Sep 21, 2023

BUY
$252.44 - $306.72 $23.8 Million - $29 Million
94,400 Added 1888.0%
99,400 $27.5 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $25.1 Million - $30.5 Million
99,400 New
99,400 $27.5 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.